Juvenile Idiopathic Arthritis (JIA) Recruiting Phase 1 Trials for Upadacitinib (DB15091)

Also known as: Arthritis, Juvenile Idiopathic / Juvenile Idiopathic Arthritis / Arthritis, Juvenile / Juvenile Arthritis / Juvenile seropositive arthritis

DBCOND0056190 (Juvenile Idiopathic Arthritis (JIA))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03725007A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic ArthritisTreatment